BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9032279)

  • 1. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
    BrĂ¼ning JC; Winnay J; Cheatham B; Kahn CR
    Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
    Harada S; Smith RM; Smith JA; White MF; Jarett L
    J Biol Chem; 1996 Nov; 271(47):30222-6. PubMed ID: 8939974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gab-1-mediated IGF-1 signaling in IRS-1-deficient 3T3 fibroblasts.
    Winnay JN; BrĂ¼ning JC; Burks DJ; Kahn CR
    J Biol Chem; 2000 Apr; 275(14):10545-50. PubMed ID: 10744748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
    Kim B; Leventhal PS; White MF; Feldman EL
    Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B; Cheng HL; Margolis B; Feldman EL
    J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade.
    Uehara T; Tokumitsu Y; Nomura Y
    Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive roles of Ras, insulin receptor substrate-1, and proteins with Src homology-2 domains in insulin signaling in Xenopus oocytes.
    Chuang LM; Hausdorff SF; Myers MG; White MF; Birnbaum MJ; Kahn CR
    J Biol Chem; 1994 Nov; 269(44):27645-9. PubMed ID: 7961682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors.
    Inoue G; Cheatham B; Kahn CR
    J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
    Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W
    Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
    Tsuruzoe K; Emkey R; Kriauciunas KM; Ueki K; Kahn CR
    Mol Cell Biol; 2001 Jan; 21(1):26-38. PubMed ID: 11113178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
    Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice.
    Yamauchi T; Tobe K; Tamemoto H; Ueki K; Kaburagi Y; Yamamoto-Honda R; Takahashi Y; Yoshizawa F; Aizawa S; Akanuma Y; Sonenberg N; Yazaki Y; Kadowaki T
    Mol Cell Biol; 1996 Jun; 16(6):3074-84. PubMed ID: 8649419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
    Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice.
    Patti ME; Sun XJ; Bruening JC; Araki E; Lipes MA; White MF; Kahn CR
    J Biol Chem; 1995 Oct; 270(42):24670-3. PubMed ID: 7559579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor substrate 1 rescues insulin action in CHO cells expressing mutant insulin receptors that lack a juxtamembrane NPXY motif.
    Chen D; Van Horn DJ; White MF; Backer JM
    Mol Cell Biol; 1995 Sep; 15(9):4711-7. PubMed ID: 7651388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.